NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»20/07/2009 [Industry news]
Gastric Cancer Breakthrough

China has developed the worlds first oral vaccine for Helicobacter pylori (HP), a bacterium closely linked to gastric cancer

 
Gastric Cancer Breakthrough China has developed the worlds first oral vaccine for Helicobacter pylori (HP), a bacterium closely linked to gastric cancer. The vaccine is designed to prevent infection by HP that inhabits parts of the stomach, believed to be strongly linked to the development of duodenal and gastric ulcers and even stomach cancer. This is the worlds first HP vaccine to finish large-scale phase-three clinical trials and become ratified as a new medicine. The vaccine has been classified as a first-grade new medicine by the State Food and Drug Administration, China\'s drug watchdog. It was developed by a research team from the Chongqing-based Third Military Medical University. During the research process, the vaccine secured eight national patents and now has full independent intellectual property rights. Clinical research shows that the vaccine has a protection rate of more than 72.1 percent against HP.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.